Sporadic lymphangioleiomyomatosis: Clinical and lung functional characteristics of 32 patients;Sporadische lymphangioleiomyomatose: Klinische und lungenfunktionelle charakteristika von 32 patientinnen

Deutsche Medizinische Wochenschrift

Volumn 133, Issue 14, 2008, Pages 705-708

  Watz, Henrik ^a   Oltmanns, A ^b   Kimmel, S ^b   Magnussen, H ^a   Wirtz, H ^b   Kirsten, D ^a  

^a KRANKENHAUS GROSSHANSDORF   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Echocardiography; Lung function; Lymphangioleiomyomatosis; Ultrasound

Indexed keywords

CARBON MONOXIDE;

ADULT; AGED; AIRWAY OBSTRUCTION; ANGIOMYOLIPOMA; ARTICLE; BODY PLETHYSMOGRAPHY; CLINICAL ARTICLE; CONTRACEPTION; COR PULMONALE; DYSPNEA; ECHOCARDIOGRAPHY; ECHOGRAPHY; ELECTROCARDIOGRAM; FEMALE; FEMALE INFERTILITY; FORCED EXPIRATORY VOLUME; GERMANY; HORMONAL THERAPY; HUMAN; HYPERINFLATION; LUNG ARTERY PRESSURE; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; LYMPHANGIOLEIOMYOMATOSIS; PNEUMOTHORAX; PREGNANCY; SPIROMETRY; ABDOMINAL TUMOR; ELECTROCARDIOGRAPHY; LUNG FUNCTION TEST; LUNG WEDGE PRESSURE; MIDDLE AGED; PATHOPHYSIOLOGY;

ABDOMINAL NEOPLASMS; ADULT; AGED; ANGIOMYOLIPOMA; DYSPNEA; ELECTROCARDIOGRAPHY; FEMALE; GERMANY; HUMANS; LYMPHANGIOLEIOMYOMATOSIS; MIDDLE AGED; PNEUMOTHORAX; PULMONARY HEART DISEASE; PULMONARY WEDGE PRESSURE; RESPIRATORY FUNCTION TESTS;

EID: 41249084801     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1067310     Document Type: Article

References (25)

1. Avila NA et al. Lymphangioleiomyomatosis: CT of diurnal variation of lymphangioleiomyomas. Radiology 2001; 221: 415-421
2. Avila NA et al. Lymphangioleiomyomatosis: abdominopelvic CT and US findings. Radiology 2000; 216: 147-153
3. Bissler JJ et al. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med 2008; 358: 140-151
4. Bittmann I, Rolf B, Amann G, Lohrs U. Recurrence of lymphangioleiomyomatosis after single lung transplantation. Hum Pathol 2003; 34: 95-98
5. Costabel U, Guzman J. Pulmonale Lymphangioleiomyomatose. Pneumologie 2002; 56: 309-315
6. Davies DM et al. Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosis. N Engl J Med 2008; 358: 200-203
7. El Hashemite N et al. Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma. Lancet 2003; 361: 1348-1349
8. Goncharova EA et al. Modulation of cell migration and invasiveness by tumor suppressor TSC2 in lymphangioleiomyomatosis. Am J Respir Cell Mol Biol 2006; 34: 473-480
9. Goncharova EA et al. Abnormal growth of smooth muscle-like cells in lymphangioleiomyomatosis: Role for tumor suppressor TSC2. Am J Respir Cell Mol Biol 2006; 34: 561-572
10. Hayashi T et al. Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM). Hum Pathol 1997; 28: 1071-1078
11. Hayashida M et al. The epidemiology of lymphangioleiomyomatosis in Japan. Respirology 2007; 12: 523-530
12. Incalzi RA et al. Electrocardiographic signs of chronic cor pulmonale. Circulation 1999; 99: 1600-1605
13. Johnson SR, Tattersfield AE. Clinical experience of lymphangioleiomyomatosis in the UK. Thorax 2000; 55: 1052-1057
14. Johnson SR, Tattersfield AE. Decline in lung function in lymphangioleiomyomatosis. Am J Respir Crit Care Med 1999; 160: 628-633
15. Johnson SR. Lymphangioleiomyomatosis. Eur Respir J 2006; 27: 1056-1065
16. Kitaichi M, Nishimura K, Itoh H, Izumi T. Pulmonary lymphangioleiomyomatosis. Am J Respir Crit Care Med 1995; 151: 527-533
17. Matsumoto Y et al. Markers of cell proliferation and expression of melanosomal antigen in lymphangioleiomyomatosis. Am J Respir Cell Mol Biol 1999; 21: 327-336
18. Moses MA, Harper J, Folkman J. Doxycycline treatment for lymphangioleiomyomatosis with urinary monitoring for MMPs. N Engl J Med 2006; 354: 2621-2622
19. Nadrous HF et al. Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Chest 2005; 128: 2393-2399
20. Ryu JH et al. The NHLBI Lymphangioleiomyomatosis Registry: Characteristics of 230 patients at enrollment. Am J Respir Crit Care Med 2006; 173: 105-111
21. Schiavina M et al. Pulmonary lymphangioleiomyomatosis in a karyotypically normal man without tuberous sclerosis complex. Am J Respir Crit Care Med 2007; 176: 96-98
22. Taveira-DaSilva AM et al, Moss J. Pulmonary artery pressure in lymphangioleiomyomatosis. Chest 2007; epub ahead of print
23. Taveira-DaSilva AM et al. Decline in lung function in patients with lymphangioleiomyomarosis treated with or without progesterone. Chest 2004; 126: 1867-1874
24. Urban T et al. Pulmonary lymphangioleiomyomatosis. Medicine (Baltimore) 1999; 78: 321-337
25. Watz H et al. Lymphangioleiomyomatosis - presence of receptor tyrosine kinases and the angiogenesis factor VEGF-A as potential therapeutic targets. Thorax 2007; 62: 559-